Current position:Home >Product >
2-((Acetyl(3,5-bis(((2,3-dihydroxypropyl)amino)carbonyl)-2,4,6-triiodophenyl)amino)methyl)-N,N'-bis(2,3-dihydroxypropyl)-2,3-dihydro-5,7-diiodo-4H-1,4-benzoxazine-6,8-dicarboxamide
2-((Acetyl(3,5-bis(((2,3-dihydroxypropyl)amino)carbonyl)-2,4,6-triiodophenyl)amino)methyl)-N,N'-bis(2,3-dihydroxypropyl)-2,3-dihydro-5,7-diiodo-4H-1,4-benzoxazine-6,8-dicarboxamide(171897-73-7)
- Name: 2-((Acetyl(3,5-bis(((2,3-dihydroxypropyl)amino)carbonyl)-2,4,6-triiodophenyl)amino)methyl)-N,N'-bis(2,3-dihydroxypropyl)-2,3-dihydro-5,7-diiodo-4H-1,4-benzoxazine-6,8-dicarboxamide
- Synonyms:171897-73-7;Iodixanol impurity F [EP];Cyclic Iodixanol;UQ2PLG139P;2-((Acetyl(3,5-bis(((2,3-dihydroxypropyl)amino)carbonyl)-2,4,6-triiodophenyl)amino)methyl)-N,N'-bis(2,3-dihydroxypropyl)-2,3-dihydro-5,7-diiodo-4H-1,4-benzoxazine-6,8-dicarboxamide;UNII-UQ2PLG139P;2-[[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilino]methyl]-6-N,8-N-bis(2,3-dihydroxypropyl)-5,7-diiodo-3,4-dihydro-2H-1,4-benzoxazine-6,8-dicarboxamide;Cyclic Iodixanol (90%);SCHEMBL12946578;IODIXANOL IMPURITY F [EP IMPURITY];Q27291209
- Molecular Formula:C33H41I5N6O14
- Molecular Weight:1380.2
- CAS Registry Number:171897-73-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 107259-17-6/Carbamic acid, [1-[1-(phenylmethyl)-3-pyrrolidinyl]ethyl]-, 1,1-dimethylethyl ester
- 144875-57-0/4-Chloro-1-(2-methylpropyl)-1H-imidazo[4,5-C]quinoline-2-methanol
- 83266-87-9/Benzyl 6-hydroxyhexanoate
- 160819-61-4/2-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
- 257885-24-8/(z)-4-(2-Isobutyrylhydrazinyl)-4-oxobut-2-enoic acid
- 162287-96-9/3'-Deaminofusarochromanone
- 162287-97-0/5-Amino-6-(4-hydroxy-2-butenoyl)-2,2-dimethyl-4-chromanone
- 169134-54-7/(2alpha,3beta)-Lup-20(29)-ene-2,3,28-triol
- 169134-55-8/[(1R,3aS,5aR,5bR,7aR,9R,10R,11aR,11bR,13aR,13bR)-9-hexadecanoyloxy-10-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]methyl hexadecanoate
- 162613-66-3/2-Butenoic acid, 2-methyl-, (4S,4aS,5R,6S,8aR,9aR)-2,4,4a,5,6,7,8,8a,9,9a-decahydro-6,9a-dihydroxy-3,4a,5-trimethyl-2-oxonaphtho[2,3-b]furan-4-yl ester, (2E)-
- 162613-67-4/2-Butenoic acid, 2-methyl-, (4S,4aS,5R,6S,8aR,9aS)-2,4,4a,5,6,7,8,8a,9,9a-decahydro-6,9a-dihydroxy-3,4a,5-trimethyl-2-oxonaphtho[2,3-b]furan-4-yl ester, (2E)-
- 173864-65-8/(3AR,4S,7S)-4-((1R)-4-{[Tert-butyl(diphenyl)silyl]oxy}-1-methylbutyl)-7-methyl-3A,6,7,8-tetrahydrocycloocta[C]furan-1,5(3H,4H)-dione
- 164332-85-8/4-((5-Amino-1H-1,2,4-triazol-3-yl)amino)-D-phenylalanine
- 161697-25-2/5-Hydroxy-3,7,8-trimethoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-4H-1-benzopyran-4-one
- 170663-16-8/N-Caffeoylalanine
- 198278-50-1/Ethyl 6,7-dihydro-5,7-diphenyl-5H-cyclopenta[b]pyridine-6-carboxylate
- 149968-29-6/1-[(Ethoxycarbonyl)oxy]ethyl 2-butyl-5-chloro-1H-imidazole-4-carboxylate
- 1357626-47-1/2-(Trifluoromethylsulfonyl)naphthalene
- 171897-72-6/4-Acetyl-2-((acetyl(3,5-bis(((2,3-dihydroxypropyl)amino)carbonyl)-2,4,6-triiodophenyl)amino)methyl)-N,N'-bis(2,3-dihydroxypropyl)-2,3-dihydro-5,7-diiodo-4H-1,4-benzoxazine-6,8-dicarboxamide
- 171897-73-7/2-((Acetyl(3,5-bis(((2,3-dihydroxypropyl)amino)carbonyl)-2,4,6-triiodophenyl)amino)methyl)-N,N'-bis(2,3-dihydroxypropyl)-2,3-dihydro-5,7-diiodo-4H-1,4-benzoxazine-6,8-dicarboxamide
- 1346751-90-3/Naronapride metabolite M1
- 176956-22-2/ethyl 5-amino-7-methoxy-1H-indole-2-carboxylate
- 152537-54-7/3-hydroxy-N,N-dimethylpropane-1-sulfonamide
- 165730-16-5/3-Amino-2,3-dihydro-2,2-dimethyl-1H-indene-5-carbonitrile
- 164653-61-6/1-(5-methoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethanone
- 37622-99-4/6-Amino-2,3-naphthalenedicarbonitrile
- 154060-13-6/Propanamide, 2-amino-3-chloro-N-pentyl-, (R)-
- 156731-61-2/Methyl 5-cyano-alpha-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methylbenzeneacetate
- 173306-83-7/Methyl 2-(tert-butoxycarbonylamino)-4-methylpent-4-enoate
- 127486-15-1/Rabeprazole metabolite active sulfenamide